No Detail Found!

Outcomes of Acute Promyelocytic Leukaemia in Paediatric Patients: Insights from a Low-Middle-Income Country

Author(s)
Shaista Naz Department of Paediatric Oncology, Combined Military Hospital,Rawalpindi,Pakistan
Tariq Ghafoor Department of Paediatric Oncology, Combined Military Hospital,Rawalpindi,Pakistan
Rabiha Manzoor Department of Paediatric Oncology, Combined Military Hospital,Rawalpindi,Pakistan
Benish Hira Department of Paediatric Oncology, Combined Military Hospital,Rawalpindi,Pakistan
Shakeel Ahmed Department of Paediatric Oncology, Combined Military Hospital,Rawalpindi,Pakistan
Awais Arshed Department of Paediatric Oncology, Combined Military Hospital,Rawalpindi,Pakistan
Abstract
Objective: To describe the prognostic variables and course of paediatric acute promyelocytic leukaemia (APL) in Pakistan. Study Design: Cohort study. Place and Duration of the Study: Department of Paediatric Oncology, Combined Military Hospital, Rawalpindi, Pakistan, from January 2012 to December 2022. Methodology: Patients aged 1-15 years, clinically con rmed APL with promyelocytic leukaemia- retinoic acid receptor alpha (PMLRARA) were enrolled. Initial admission included a thorough examination, recording demographic and clinical data, reporting time, prior treatment, and socioeconomic status. Statistical analysis used SPSS 25.0, with signi cance at p <0.05. Results: This study included 50 cases of APL. Out of which, 32 (64%) were males and 18 (34%) were females. The mean age at diagnosis was 7.02 ± 3.86 years. Pallor (96%) and fever (88%) were common presentations. The average white blood cell count was 28.70 ± 35.39 x109/L. Treatment protocols include 48% International Consortium for Childhood (ICC)-APL, and 52% arsenic trioxide (ATO). High-risk cases were 54%. Neutropenic fever and di erentiation syndrome were common induction complicatioDnse.lays over one month increased induction deaths (6.7 to 35%, p = 0.011), reducing disease-free survival (DFS), (76.7 to 35%, p = 0.001), and overall survival (OS), (80 to 45%, p = 0.007). After 40.90 ± 45.19 months follow-up, 10-year OS and DFS were 66.0% and 60.0%, respectively. The best OS and DFS, at 80%, were observed in standard-risk cases treated with ATO. Conclusion: Neutropenic fever and bleeding were the primary causes of mortality in paediatric APL induction. Treatment delay was a key prognostic factor. ATO-based therapy o ered safer, improved DFS, and OS suitable for primary healthcare settings.
Publication Details
Page(s) 974-980
Published Journal: Journal of College of Physicians and Surgeons--Pakistan : JCPSP, Volume: 34, Issue: 8, Year: 2024

Request the full text from PASTIC

Keywords
chemotherapy, Neutropenic fever, Acute promyelocytic leukaemia
0

Citations

0

Downloads

83

Views